241 related articles for article (PubMed ID: 20493209)
1. Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague-Dawley rats.
Killinger BA; Peet MM; Baker LE
Pharmacol Biochem Behav; 2010 Sep; 96(3):260-5. PubMed ID: 20493209
[TBL] [Abstract][Full Text] [Related]
2. Salvinorin B derivatives, EOM-Sal B and MOM-Sal B, produce stimulus generalization in male Sprague-Dawley rats trained to discriminate salvinorin A.
Peet MM; Baker LE
Behav Pharmacol; 2011 Sep; 22(5-6):450-7. PubMed ID: 21814135
[TBL] [Abstract][Full Text] [Related]
3. The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys.
Butelman ER; Harris TJ; Kreek MJ
Psychopharmacology (Berl); 2004 Mar; 172(2):220-4. PubMed ID: 14586540
[TBL] [Abstract][Full Text] [Related]
4. The discriminative effects of the kappa-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects.
Butelman ER; Rus S; Prisinzano TE; Kreek MJ
Psychopharmacology (Berl); 2010 Jun; 210(2):253-62. PubMed ID: 20084367
[TBL] [Abstract][Full Text] [Related]
5. The hallucinogen derived from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in rats.
Willmore-Fordham CB; Krall DM; McCurdy CR; Kinder DH
Neuropharmacology; 2007 Sep; 53(4):481-6. PubMed ID: 17681558
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats.
Baker LE; Panos JJ; Killinger BA; Peet MM; Bell LM; Haliw LA; Walker SL
Psychopharmacology (Berl); 2009 Apr; 203(2):203-11. PubMed ID: 19153716
[TBL] [Abstract][Full Text] [Related]
7. Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.
Cunningham CW; Rothman RB; Prisinzano TE
Pharmacol Rev; 2011 Jun; 63(2):316-47. PubMed ID: 21444610
[TBL] [Abstract][Full Text] [Related]
8. A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.
Cruz A; Domingos S; Gallardo E; Martinho A
Phytochemistry; 2017 May; 137():9-14. PubMed ID: 28190678
[TBL] [Abstract][Full Text] [Related]
9. Failure of ibogaine to produce phencyclidine-like discriminative stimulus effects in rats and monkeys.
Jones HE; Li H; Balster RL
Pharmacol Biochem Behav; 1998 Feb; 59(2):413-8. PubMed ID: 9476989
[TBL] [Abstract][Full Text] [Related]
10. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
[TBL] [Abstract][Full Text] [Related]
11. Chronic phenethylamine hallucinogen treatment alters behavioral sensitivity to a metabotropic glutamate 2/3 receptor agonist.
Benneyworth MA; Smith RL; Sanders-Bush E
Neuropsychopharmacology; 2008 Aug; 33(9):2206-16. PubMed ID: 17957214
[TBL] [Abstract][Full Text] [Related]
12. The ketamine analogue methoxetamine generalizes to ketamine discriminative stimulus in rats.
Chiamulera C; Armani F; Mutti A; Fattore L
Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):204-10. PubMed ID: 26866970
[TBL] [Abstract][Full Text] [Related]
13. Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse.
Fantegrossi WE; Kugle KM; Valdes LJ; Koreeda M; Woods JH
Behav Pharmacol; 2005 Dec; 16(8):627-33. PubMed ID: 16286814
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the discriminative stimulus effects of N-methyl- D-aspartate ligands under different ethanol training conditions in the cynomolgus monkey ( Macaca fascicularis).
Vivian JA; Waters CA; Szeliga KT; Jordan K; Grant KA
Psychopharmacology (Berl); 2002 Jul; 162(3):273-81. PubMed ID: 12122485
[TBL] [Abstract][Full Text] [Related]
15. Re-evaluation of the discriminative stimulus effects of lysergic acid diethylamide with male and female Sprague-Dawley rats.
Herr KA; Baker LE
Behav Pharmacol; 2020 Dec; 31(8):776-786. PubMed ID: 32960851
[TBL] [Abstract][Full Text] [Related]
16. Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A.
Valdés LJ
J Psychoactive Drugs; 1994; 26(3):277-83. PubMed ID: 7844657
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination.
Baker LE; Taylor MM
Pharmacol Biochem Behav; 1997 Aug; 57(4):737-48. PubMed ID: 9259001
[TBL] [Abstract][Full Text] [Related]
18. Role of the NMDA receptor NR2B subunit in the discriminative stimulus effects of ketamine.
De Vry J; Jentzsch KR
Behav Pharmacol; 2003 May; 14(3):229-35. PubMed ID: 12799525
[TBL] [Abstract][Full Text] [Related]
19. Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action.
Marona-Lewicka D; Nichols DE
Pharmacol Biochem Behav; 2007 Oct; 87(4):453-61. PubMed ID: 17618679
[TBL] [Abstract][Full Text] [Related]
20. Behavioral effects associated with chronic ketamine or remacemide exposure in rats.
Wright LK; Pearson EC; Hammond TG; Paule MG
Neurotoxicol Teratol; 2007; 29(3):348-59. PubMed ID: 17291718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
